Copyright: ©Author(s) 2026.
World J Gastroenterol. Sep 7, 2026; 32(33): 118672
Published online Sep 7, 2026. doi: 10.3748/wjg.118672
Published online Sep 7, 2026. doi: 10.3748/wjg.118672
Figure 1 Stage-dependent variations in programmed death ligand 1 expression and immune cell composition.
MDSC: Myeloid-derived suppressor cell; PD-L1: Programmed death ligand 1; CAF: Cancer-associated fibroblasts.
- Citation: Tu HS, Chen ML, Hong J, Li S, He L. Stage-aware programmed death ligand 1 assessment in gastric cancer: Implications for perioperative immunotherapy. World J Gastroenterol 2026; 32(33): 118672
- URL: https://www.wjgnet.com/1007-9327/full/v32/i33/118672.htm
- DOI: https://dx.doi.org/10.3748/wjg.118672